Fullscale_Intervention Study: Genetic Risk Communication in Coronary Heart Disease and Wearables

NANot yet recruitingINTERVENTIONAL
Enrollment

414

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2026

Conditions
Fitness TrackersSedentary TimeGenetic Predisposition to DiseaseCoronary Heart Disease
Interventions
GENETIC

Genetic Risk Estimate+Health Coaching

The genetic risk information includes individual remaining-lifetime and 10-year genetic risk estimates for CHD as well as a dichotomized genetic risk category: 'increased genetic risk' (if their genetic risk is higher than the average population risk) or 'no increased genetic risk' (if their genetic risk is not higher than the average population risk). Health coaching will be incorporated through phone or Zoom calls to provide an explanation of each participant's own genetic risk of CHD as well as lifestyle modification measures.

DEVICE

Genetic Risk Estimate + Fitbit Functions+Health Coaching

"Intervention: Device: Genetic Risk Estimate + Fitbit Functions The genetic risk information includes individual remaining-lifetime and 10-year genetic risk estimates for CHD as well as a dichotomized genetic risk category: 'increased genetic risk' or 'no increased genetic risk'.~The two unique Fitbit functions are step goal setting and prompts. Individualized daily step goals will be set to be 10% higher than participants' own baseline Fitbit step counts. The 'Reminder To Move' function of Fitbit will be used as a prompt to remind participants to reduce sedentary time and walk at least 250 steps/hour within a specified timeframe (i.e., from 9am to 10pm in the proposed research). If the user has not accumulated at least 250 steps/hour, a reminder (for example, 150 steps to go) will appear on the Fitbit screen at 10 minutes before the hour (for example, at 10:50 a.m.) and cause the device to vibrate. Health coaching will be incorporated as well"

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT05789966 - Fullscale_Intervention Study: Genetic Risk Communication in Coronary Heart Disease and Wearables | Biotech Hunter | Biotech Hunter